NewsFebruary 17, 2020More pressure on Bayer as EU approves Novartis’ Beovu in wet AMD Share XMore pressure on Bayer as EU approves Novartis’ Beovu in wet AMDhttps://pharmaphorum.com/news/more-pressure-on-bayer-as-eu-approves-novartis-beovu-in-wet-amd/
NewsFebruary 17, 2020Blockbusters in waiting: drug launches to watch in 2020 Share XBlockbusters in waiting: drug launches to watch in 2020https://pharmaphorum.com/news/blockbusters-in-waiting-drug-launches-to-watch-in-2020/
NewsFebruary 4, 2020BMS plans another tack as EU regulators knock back lung cancer combo Share XBMS plans another tack as EU regulators knock back lung cancer combohttps://pharmaphorum.com/news/bms-withdraws-eu-filing-for-opdivoyervoy-in-nsclc/
NewsFebruary 4, 2020FDA sets June date for latest review of Merck’s last-ditch antibiotic Share XFDA sets June date for latest review of Merck’s last-ditch antibiotichttps://pharmaphorum.com/news/fda-sets-june-date-for-latest-review-of-mercks-last-ditch-antibiotic/
NewsFebruary 3, 2020Novo Nordisk nears EU okay for oral GLP-1 drug Rybelsus after CHMP nod Share XNovo Nordisk nears EU okay for oral GLP-1 drug Rybelsus after CHMP nodhttps://pharmaphorum.com/news/novo-nordisk-nears-eu-okay-for-oral-semaglutide-after-chmp-nod/
NewsFebruary 3, 2020Alnylam gets CHMP backing for second gene-silencing drug Givlaari Share XAlnylam gets CHMP backing for second gene-silencing drug Givlaarihttps://pharmaphorum.com/news/alnylam-gets-chmp-backing-for-second-gene-silencing-drug-givlaari/
NewsJanuary 2, 2020Melinta is latest antibiotics biotech to file for bankruptcy as superbug fears mount Share XMelinta is latest antibiotics biotech to file for bankruptcy as superbug fears mounthttps://pharmaphorum.com/news/melinta-is-latest-antibiotics-biotech-to-file-for-bankruptcy-as-superbug-fears-mount/
NewsDecember 20, 2019Merck claims first-ever FDA approval for an Ebola vaccine Share XMerck claims first-ever FDA approval for an Ebola vaccinehttps://pharmaphorum.com/news/merck-claims-first-ever-fda-approval-for-an-ebola-vaccine/
NewsDecember 17, 2019Novartis top of pile in European pharma in 2020, say Jefferies analysts Share XNovartis top of pile in European pharma in 2020, say Jefferies analystshttps://pharmaphorum.com/news/novartis-top-of-pile-in-european-pharma-say-jefferies-analysts/
NewsDecember 16, 2019Merck’s last-resort antibiotic Recarbrio nears EU approval Share XMerck’s last-resort antibiotic Recarbrio nears EU approvalhttps://pharmaphorum.com/news/mercks-last-resort-antibiotic-recarbrio-nears-eu-approval/
NewsDecember 16, 2019Novartis’ blockbuster hope Beovu clears EMA advisory panel Share XNovartis’ blockbuster hope Beovu clears EMA advisory panelhttps://pharmaphorum.com/news/novartis-blockbuster-hope-beovu-clears-ema-advisory-panel/
NewsDecember 12, 2019UCB/Amgen’s Evenity approved in Europe after appeal Share XUCB/Amgen’s Evenity approved in Europe after appealhttps://pharmaphorum.com/news/ucb-amgens-evenity-approved-in-europe-after-appeal/
